RIsk of Apoplexia Cerebri in CLOpidogrel Non-responders "RISCLON"


Phase N/A Results N/A

Summary of Purpose

Stroke patients are given prophylactic treatment with clopidogrel to prevent new strokes. Some of these patients (the investigators don't know precisely how many, but previous studies indicate 4-34%) are so called non-responders, when you measure on a blood sample from the patient. These patients may have an increased... Trial Stopped: Lack of feasiability

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 June 2017.

1 Dec 2012 19 Mar 2014 22 Nov 2016 22 Nov 2016 1 Jun 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Probability Sample


Not available